For citations:
Mikhaylenko D.S., Sergienko S.A., Kuznetsova E.B., Zaborsky I.N., Martynov M.I., Loran O.B., Efremov G.D., Samoylova S.A., Alekseev B.Ya., Musatova V.V., Bure I.V., Nemtsova M.V. FGFR3, TERT, ТР53 mutations and the FGFR3 gene expression in bladder cancer as prognostic markers. Cancer Urology. 2021;17(1):89-100. (In Russ.) https://doi.org/10.17650/1726-9776-2021-17-1-89-100
Email this article 